According to a recent LinkedIn post from Kardigan, the company is drawing attention to an upcoming educational webinar on wearable devices and heart health hosted by the Genetic Cardiomyopathy Awareness Consortium. The post notes that the May 20 event is free, open to the public, and focused on how heart data from wearables may inform living with genetic cardiomyopathy and related conditions.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post specifies that Prolaio supported the event and that a Prolaio-affiliated speaker will participate, while emphasizing that content reflects the views of presenters and GCAC rather than serving as medical advice or product promotion. Kardigan also highlights that it does not endorse any specific study or device, signaling a cautious stance that may appeal to investors focused on regulatory and compliance risk in the digital health and cardiovascular technology space.